Pacira Biosciences, Inc. (PCRX)
24.77
+0.35
(+1.43%)
USD |
NASDAQ |
Dec 09, 16:00
24.75
-0.02
(-0.08%)
Pre-Market: 20:00
Pacira Biosciences Profit Margin (Quarterly): 3.03% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Hologic, Inc. | 17.85% |
| CorMedix, Inc. | -- |
| ADMA Biologics, Inc. | 27.14% |
| Atara Biotherapeutics, Inc. | -124.6% |
| AnaptysBio, Inc. | 19.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.81% |
| Return on Assets | 1.43% |
| Return on Invested Capital | 1.58% |
| Gross Profit Margin (Quarterly) | 72.93% |
| Operating Margin (Quarterly) | 7.33% |
| Return on Net Operating Assets | 2.41% |